These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12183534)

  • 1. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.
    Martin D; Rioux S; Gagnon E; Boyer M; Hamel J; Charland N; Brodeur BR
    Infect Immun; 2002 Sep; 70(9):4897-901. PubMed ID: 12183534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.
    Madoff LC; Michel JL; Gong EW; Rodewald AK; Kasper DL
    Infect Immun; 1992 Dec; 60(12):4989-94. PubMed ID: 1452329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
    Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
    Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.
    Brodeur BR; Boyer M; Charlebois I; Hamel J; Couture F; Rioux CR; Martin D
    Infect Immun; 2000 Oct; 68(10):5610-8. PubMed ID: 10992461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment.
    Madureira P; Andrade EB; Gama B; Oliveira L; Moreira S; Ribeiro A; Correia-Neves M; Trieu-Cuot P; Vilanova M; Ferreira P
    PLoS Pathog; 2011 Nov; 7(11):e1002363. PubMed ID: 22114550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotypic vaccination against group B streptococci.
    Beninati C; Oggioni M; Mancuso G; Midiri A; Polonelli L; Pozzi G; Teti G
    Int Rev Immunol; 2001; 20(2):263-73. PubMed ID: 11878769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Pinel J; Kasper DL
    J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
    Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
    Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
    J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
    Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal mouse model of group B streptococcal infection.
    Rodewald AK; Onderdonk AB; Warren HB; Kasper DL
    J Infect Dis; 1992 Sep; 166(3):635-9. PubMed ID: 1500748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group B streptococcal vaccines.
    Baker CJ; Kasper DL
    Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
    Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
    Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.
    Bernardini R; Aufieri R; Detcheva A; Recchia S; Cicconi R; Amicosante M; Montesano C; Rossi P; Tchidjou HK; Petrunov B; Orefici G; Mattei M
    J Matern Fetal Neonatal Med; 2017 Dec; 30(23):2844-2850. PubMed ID: 27973991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccine based on a surface immunogenic protein mixed with alum promotes a decrease in Streptococcus agalactiae vaginal colonization in a mouse model.
    Diaz-Dinamarca DA; Soto DA; Leyton YY; Altamirano-Lagos MJ; Avendaño MJ; Kalergis AM; Vasquez AE
    Mol Immunol; 2018 Nov; 103():63-70. PubMed ID: 30205305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
    Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
    J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.
    Larsson C; Stålhammar-Carlemalm M; Lindahl G
    Infect Immun; 1996 Sep; 64(9):3518-23. PubMed ID: 8751893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.